Starpharma (SPL.AU)

Starpharma share price today, ATLAS forecast and fair value

Healthcare · Biotechnology · Australian Securities Exchange · Australia

A$0.475▲ +2.15%

Prices as of Oct 26, 2026 · AUD

ATLAS fair value

ATLAS has no fair value for this stock today.

Chance of rising in 1 month

45%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Starpharma in ATLAS

ATLAS's own quantitative analysis, all in one place.

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.

See everything included

Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

On Starpharma

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.

And for you

ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

Get started →

Plans from €3.99 a month.

ATLAS's model gives Starpharma a 45% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between A$0.394 and A$0.540; in 9 out of 10, between A$0.298 and A$0.715. Estimated annual volatility is 97%.

Price, last 12 months (weekly close)

Key numbers

Market cap: A$355M
Market cap (USD): $249M
52-week high: A$0.875
52-week low: A$0.305
Revenue (12 months): A$12.7M
Gross margin: 6.1%
Net margin: -58.9%
Beta: 0.72

What this means

ATLAS does not publish a fair value for SPL.AU right now, but it does show its odds of rising: close to a coin flip.

Over the last 52 weeks SPL.AU has traded between A$0.305 and A$0.875. Today it is 45.7% below that high and 56% above its low.

Its beta is 0.72: it tends to move less than the market.

About the company

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.

Want to see everything about Starpharma?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What does Starpharma do?

What is the chance SPL.AU goes up next month?

45%: close to a coin flip. In half of the simulated outcomes, SPL.AU ends the month between A$0.394 and A$0.540.

How big is Starpharma and what is its P/E ratio?

Starpharma's market capitalization is A$355M. We do not show a P/E because it has no positive earnings to base one on.

How volatile is SPL.AU?

ATLAS estimates annual volatility at 97%. In a typical month, half of the outcomes end between A$0.394 and A$0.540.

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer